On the contrary, other studies have shown that transgenic mice overexpressing constitutively active FOXO1 (CA-FoxO1) in liver exhibit decreased fasting TG and cholesterol despite of hyperinsulinemia and suppressed hepatic DNL and Srebp1-c expression [24, 94, 95]. The gene discussed is FOXO1; the disease is Hyperinsulinemia.